Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China
· Delayed Price · Currency is CNY 255.06
-3.44 (-1.33%)
At close: Mar 9, 2026
SHA:688506 Revenue
In the year 2025, Sichuan Biokin Pharmaceutical had annual revenue of 2.52B CNY, down -56.72%. Sichuan Biokin Pharmaceutical had revenue of 454.22M in the quarter ending December 31, 2025, with 183.61% growth.
Revenue
2.52B
Revenue Growth
-56.72%
P/S Ratio
41.79
Revenue / Employee
999.65K
Employees
2,824
Market Cap
105.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.52B | -3.30B | -56.72% |
| Dec 31, 2024 | 5.82B | 5.26B | 936.31% |
| Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
| Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
| Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Zhejiang NHU Company | 22.47B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Huadong Medicine | 43.09B |
| Shenzhen Salubris Pharmaceuticals | 4.25B |
| China Resources Sanjiu Medical & Pharmaceutical | 31.63B |
| Beijing Tongrentang | 18.09B |
| Changchun High-Tech Industry (Group) | 12.88B |